June 25, 2025 - 17:28

Banking technology company Thought Machine has teamed up with technology services provider DXC Technology to enhance the digital transformation efforts of financial institutions. This partnership aims to leverage Thought Machine's cutting-edge cloud-native core banking technology, which is designed to support modern banking needs and streamline operations.
By integrating Thought Machine's innovative solutions with DXC's extensive technology services, the collaboration seeks to empower banks to modernize their legacy systems and improve customer experiences. The alliance will enable financial institutions to adopt more agile and flexible banking models, positioning them to respond swiftly to market changes and customer demands.
As banks increasingly face pressure to innovate, this partnership represents a significant step towards providing improved financial services. Both companies are optimistic that their combined expertise will drive growth and efficiency in the banking sector, ultimately benefiting customers with enhanced services and solutions.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...